Cryo Cell International Inc (CCEL) — SEC Filings
Cryo Cell International Inc (CCEL) — 20 SEC filings. Latest: 8-K (Nov 12, 2025). Includes 9 8-K, 6 10-Q, 2 DEF 14A.
View Cryo Cell International Inc on SEC EDGAR
Overview
Cryo Cell International Inc (CCEL) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 12, 2025: On November 12, 2025, CRYO CELL INTERNATIONAL, INC. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. The company is incorporated in Delaware and its principal executive offices are located in Oldsmar, Florida.
Sentiment Summary
Across 20 filings, the sentiment breakdown is: 2 bearish, 18 neutral. The dominant filing sentiment for Cryo Cell International Inc is neutral.
Filing Type Overview
Cryo Cell International Inc (CCEL) has filed 9 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 1 10-Q/A with the SEC between Feb 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (20)
Risk Profile
Risk Assessment: Of CCEL's 20 recent filings, 2 were flagged as high-risk, 8 as medium-risk, and 10 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $7.83M |
| Net Income | $1.39M |
| Cash Position | $265,207 |
Key Executives
- David I. Portnoy
- Mark L. Portnoy
- Harold D. Berger
- Daniel Mizrahi
- Jill Taymans
- Oleg Mikulinsky
Industry Context
The stem cell banking industry, while offering long-term health benefits, is capital-intensive and subject to evolving regulatory landscapes. Companies in this sector often face challenges related to customer acquisition costs, technological advancements, and the long-term storage and management of biological materials. Competition can arise from both established players and new entrants.
Top Tags
8-K (4) · 10-Q (4) · financials (4) · 8-k (3) · filing (3) · sec-filing (3) · other-events (2) · Biotechnology (2) · Stem Cell Banking (2) · Financial Performance (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 001-40767 | Identifies the company's filing history with the SEC. |
| IRS Employer Identification No. | 22-3023093 | Company's tax identification number. |
| Total Revenue | $7.83M | Decreased by 2.9% for the three months ended August 31, 2025, compared to $8.07M in the prior year. |
| Net Income | $1.39M | Decreased by 38.7% for the nine months ended August 31, 2025, compared to $2.26M in the prior year. |
| Cash and Cash Equivalents | $265,207 | Decreased by 52.8% from $560,960 at November 30, 2024, to August 31, 2025. |
| Interest Expense | $1.58M | Increased by 41.5% for the nine months ended August 31, 2025, compared to $1.12M in the prior year. |
| Losses on Marketable Securities | $604,619 | A significant reversal from $1.06M in gains for the nine months ended August 31, 2024. |
| Dividends Paid | $3.23M | A new cash outflow for the nine months ended August 31, 2025, with no dividends paid in the prior year. |
| Total Stockholders' Deficit | $14.83M | Increased from $13.22M at November 30, 2024, to August 31, 2025. |
| Net Cash from Operating Activities | $4.20M | Increased from $3.85M for the nine months ended August 31, 2024, to August 31, 2025. |
| Annual Meeting Date | October 21, 2025 | Date for Cryo-Cell International, Inc.'s Annual Meeting of Stockholders |
| Record Date | September 15, 2025 | Date for determining stockholders entitled to vote at the Annual Meeting |
| Shares Outstanding | 8,062,159 | Number of common shares outstanding on the record date |
| Director Nominees | 4 | Number of individuals nominated for election to the Board of Directors |
| Board Meetings | 8 | Number of Board of Directors meetings held during fiscal year ended November 30, 2024 |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Cryo Cell International Inc (CCEL)?
Cryo Cell International Inc has 20 recent SEC filings from Feb 2024 to Nov 2025, including 9 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CCEL filings?
Across 20 filings, the sentiment breakdown is: 2 bearish, 18 neutral. The dominant sentiment is neutral.
Where can I find Cryo Cell International Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Cryo Cell International Inc (CCEL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Cryo Cell International Inc?
Key financial highlights from Cryo Cell International Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for CCEL?
The investment thesis for CCEL includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Cryo Cell International Inc?
Key executives identified across Cryo Cell International Inc's filings include David I. Portnoy, Mark L. Portnoy, Harold D. Berger, Daniel Mizrahi, Jill Taymans and 1 others.
What are the main risk factors for Cryo Cell International Inc stock?
Of CCEL's 20 assessed filings, 2 were flagged high-risk, 8 medium-risk, and 10 low-risk.
What are recent predictions and forward guidance from Cryo Cell International Inc?
Forward guidance and predictions for Cryo Cell International Inc are extracted from SEC filings as they are enriched.